ALBERT DAVID
Back to Cashflow Statement
|
ALBERT DAVID Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-8.27 Cr | ₹-6.36 Cr | ₹-1.59 Cr | ₹-1.71 Cr | ₹-10 Cr |
What is the latest Cash Flow from Financing Activities ratio of ALBERT DAVID ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-8.27 Cr |
Mar2023 | ₹-6.36 Cr |
Mar2022 | ₹-1.59 Cr |
Mar2021 | ₹-1.71 Cr |
Mar2020 | ₹-10 Cr |
How is Cash Flow from Financing Activities of ALBERT DAVID Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-8.27 Cr | Negative | |
Mar2023 | ₹-6.36 Cr | Negative | |
Mar2022 | ₹-1.59 Cr | Negative | |
Mar2021 | ₹-1.71 Cr | Negative | |
Mar2020 | ₹-10 Cr | - |
Compare Cash Flow from Financing Activities of peers of ALBERT DAVID
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALBERT DAVID | ₹752.4 Cr | -2.4% | -7.7% | 35.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹440,830.0 Cr | -2.2% | 1.7% | 41.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,644.0 Cr | -4.6% | -1.6% | 45.8% | Stock Analytics | |
CIPLA | ₹120,742.0 Cr | -2.8% | 1.8% | 15.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹114,366.0 Cr | -0.2% | 9.2% | 15.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,766.9 Cr | -0.9% | -0.1% | 41.1% | Stock Analytics |
ALBERT DAVID Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALBERT DAVID | -2.4% |
-7.7% |
35.8% |
SENSEX | -0.5% |
-4.4% |
9.5% |
You may also like the below Video Courses